Abeona Therapeutics Inc. (ABEO) insider trading.
In Q3 2026, insiders at Abeona Therapeutics Inc. reported 11 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $1.2M.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 11
- Net shares, P minus S
- -185,413
- Insiders
- 6
- Last filed
- 2026-09-29
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Vazzano Joseph Walter | Officer · Chief Financial Officer | 3 | 0 | 3 |
| Vasanthavada Madhav | Officer · Chief Commercial Officer | 2 | 0 | 2 |
| O'Malley Brendan M. | Officer · SVP, Chief Legal Officer | 2 | 0 | 2 |
| Seshadri Vishwas | Director, Officer · Chief Executive Officer | 2 | 0 | 2 |
| Alvino Mark | Director | 1 | 0 | 1 |
| Alland Leila | Director | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Vasanthavada Madhav | S (D) | 4,902 | $5.16 | 285,721 | Form 4 |
| 2026-09-29 | O'Malley Brendan M. | S (D) | 6,727 | $5.16 | 421,226 | Form 4 |
| 2026-09-29 | Vazzano Joseph Walter | S (D) | 9,191 | $5.16 | 482,888 | Form 4 |
| 2026-09-29 | Seshadri Vishwas | S (D) | 19,608 | $5.16 | 1,286,500 | Form 4 |
| 2026-09-01 | Alvino Mark | S (D) | 15,000 | $5.86 | 62,065 | Form 4 |
| 2026-07-21 | Vazzano Joseph Walter | S (D) | 1,478 | $6.53 | 492,079 | Form 4 |
| 2026-07-09 | Vasanthavada Madhav | S (D) | 12,606 | $6.96 | 290,623 | Form 4 |
| 2026-07-09 | O'Malley Brendan M. | S (D) | 12,050 | $6.96 | 427,953 | Form 4 |
| 2026-07-09 | Seshadri Vishwas | S (D) | 67,971 | $6.96 | 1,306,108 | Form 4 |
| 2026-07-09 | Vazzano Joseph Walter | S (D) | 24,880 | $6.96 | 493,557 | Form 4 |
| 2026-06-30 | Alland Leila | S (D) | 11,000 | $5.92 | 162,614 | Form 4 |
Transaction codes in this quarter
Get ABEO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=318306&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ABEO company page · Abeona Therapeutics Inc. on SEC.gov
Questions
Are insiders buying or selling Abeona Therapeutics Inc. (ABEO)?
In Q3 2026, insiders at Abeona Therapeutics Inc. reported 11 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $1.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Abeona Therapeutics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/abeo.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.